SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1061 the competition - REPORT OF RESULTS FROM HEAD-TO-HEAD CLINICAL TRIAL OF COPAXONDavid Israel-Rosen-3/5/2000
1060 MARIJUANA DERIVATIVES IMPROVE SPASTICITY AND TREMOR IN MICE WITH MS-LIKE DISEASDavid Israel-Rosen-3/5/2000
1059 Cacaito: It is my understanding that Aviv was so encouraged with P2C3 results John Goodman-3/4/2000
1058 Rat studies will not a Bgen market price bring, not even 25%, Pharmos has excelCacaito-3/4/2000
1057 Insha'Allah!!Zvi Steinberg-3/4/2000
1056 Nature is WORLD CLASS which is closely followed by everyone on wall street and David Israel-Rosen-3/4/2000
1055 Yes, this is the article. But it appears that Pharmos has done it's own resMoney Mood-3/4/2000
1054 Nature 404, 84 - 87 (2000) ¸ Macmillan Publishers Ltd. Cannabinoids coDavid Israel-Rosen-3/4/2000
1053 Pharmos phase II already released results from cohort-1(75 mg) and cohort-2(150Cacaito-3/4/2000
1052 Cacaito, Thanks. I am glad that Pharmos is on this. I am a novice here. DoesMoney Mood-3/4/2000
1051ncbi.nlm.nih.gov Above link reference is from Pharmos Israel labs, mice models Cacaito-3/4/2000
1050 This would possibly make Pharmos as big as Biogen. The article has results of BMoney Mood-3/3/2000
1049 Would that be to change Pharmos future for better or a turn for the worst.....Tjjetstream-3/3/2000
1048 Hello, thread, There is an article in the last issue of "Nature" magMoney Mood-3/3/2000
1047 i was telling a friend just now that those loyal and knowlegeable PARS investorLTK007-3/3/2000
1046 Congrats all faithful PARS holders.... I suspect some millionaires have been crLLCF-3/3/2000
1045 LT I got in two day ago at 7 7/16 Do I see at next IMCL RichRich-3/2/2000
1044 Man is this stock attracting some strong buying. Charts look like they are abouLT-3/2/2000
1043 While the following doesn't directly relate to HU211, it may help lessen thLLLefty-3/1/2000
1042 Update post.messages.yahoo.comyosi s-2/26/2000
1041 Don't you think that PARS has signaled how Cohort III of the Phase II hu-21Rick Strange-2/25/2000
1040 You are welcome, OR33. Also, congrats on Thom Calandra...I read the post on YaRon-2/25/2000
1039 hi yosi we are backDavid Israel-Rosen-2/25/2000
1038 Nice to see all the posters. I think that Pharmos is just in the begining of ityosi s-2/24/2000
1037 www.israelinvestor.comDavid Israel-Rosen-2/24/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News